Emergent BioSolutions Inc. (EBS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Emergent BioSolutions Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$7.09
+6.30% today
Market cap
$342M
Overall quality
40/100
Kronos AI 30-day
−10.3%
1 of 8 simulated paths end higher
Emergent BioSolutions Inc. (EBS) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $342M. It trades at $7.09, up 6.30% today. Its overall quality score is 40 out of 100, ranked against the whole US market. 2 analysts' average target of $10.00 implies +41.0% from today's price. Kronos AI's 30-day forecast is −10.3% (1 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $10.00 |
| Low – high | $10.00 – $10.00 |
| Analysts | 2 |
| Upside to average | +41.0% |
Kronos AI 30-day forecast
| Expected close | $5.98 (−10.3%) |
| Likely range | −17.7% … +6.0% |
| As of | 2026-10-27 |
1 of 8 simulated paths end higher.
Quality scores
| Profitability | 34 |
| Solvency | 24 |
| Growth | 61 |
| Overall | 40 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.